Application of chlorpromazine in preparation of coronavirus inhibitor
The invention discloses an application of chlorpromazine in preparation of a coronavirus inhibitor. The invention provides application of chlorpromazine or pharmaceutically acceptable salt thereof, which is (a) or (b) or (c) or (d) as follows: (a) application in preparation of a coronavirus inhibito...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MEI JIAJIA MINEYAMA WEI TAO ZHAO JIANYUAN REN LILI |
| description | The invention discloses an application of chlorpromazine in preparation of a coronavirus inhibitor. The invention provides application of chlorpromazine or pharmaceutically acceptable salt thereof, which is (a) or (b) or (c) or (d) as follows: (a) application in preparation of a coronavirus inhibitor; (b) application in inhibition of coronavirus; (c) application in product preparation; the product is used for treating diseases caused by coronavirus infection. And (d) application in treating diseases caused by coronavirus infection. Experiments prove that chlorpromazine has good anti-SARS-CoV-2 activity and/or anti-HCoV-OC43, and has an important application prospect in the treatment of SARS-CoV-2 infection and/or HCoV-OC43 infection.
本发明公开了氯丙嗪在制备冠状病毒抑制剂中的应用。本发明提供了氯丙嗪或其在药学上可接受的盐的应用，为如下(a)或(b)或(c)或(d)：(a)在制备冠状病毒抑制剂中的应用；(b)在抑制冠状病毒中的应用；(c)在制备产品中的应用；所述产品的用途为治疗冠状病毒感染引起的疾病；(d)在治疗冠状病毒感染引起的疾病中的应用。本发明通过实验证明氯丙嗪具有良好的抗SARS-CoV-2活性和/或抗HCoV-OC43，具有重要的治疗SARS-CoV-2感染和/或HCoV-OC43感染的应用前景。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116549456A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116549456A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116549456A3</originalsourceid><addsrcrecordid>eNrjZHB1LCjIyUxOLMnMz1PIT1NIzsjJLyooys9NrMrMS1XIzFMoKEotSCxCKMgvys9LLMssKi0GymZkJmWW5BfxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQzNTE0sTUzNHY2LUAABcDjQo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of chlorpromazine in preparation of coronavirus inhibitor</title><source>esp@cenet</source><creator>MEI JIAJIA ; MINEYAMA ; WEI TAO ; ZHAO JIANYUAN ; REN LILI</creator><creatorcontrib>MEI JIAJIA ; MINEYAMA ; WEI TAO ; ZHAO JIANYUAN ; REN LILI</creatorcontrib><description>The invention discloses an application of chlorpromazine in preparation of a coronavirus inhibitor. The invention provides application of chlorpromazine or pharmaceutically acceptable salt thereof, which is (a) or (b) or (c) or (d) as follows: (a) application in preparation of a coronavirus inhibitor; (b) application in inhibition of coronavirus; (c) application in product preparation; the product is used for treating diseases caused by coronavirus infection. And (d) application in treating diseases caused by coronavirus infection. Experiments prove that chlorpromazine has good anti-SARS-CoV-2 activity and/or anti-HCoV-OC43, and has an important application prospect in the treatment of SARS-CoV-2 infection and/or HCoV-OC43 infection.
本发明公开了氯丙嗪在制备冠状病毒抑制剂中的应用。本发明提供了氯丙嗪或其在药学上可接受的盐的应用，为如下(a)或(b)或(c)或(d)：(a)在制备冠状病毒抑制剂中的应用；(b)在抑制冠状病毒中的应用；(c)在制备产品中的应用；所述产品的用途为治疗冠状病毒感染引起的疾病；(d)在治疗冠状病毒感染引起的疾病中的应用。本发明通过实验证明氯丙嗪具有良好的抗SARS-CoV-2活性和/或抗HCoV-OC43，具有重要的治疗SARS-CoV-2感染和/或HCoV-OC43感染的应用前景。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230808&DB=EPODOC&CC=CN&NR=116549456A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230808&DB=EPODOC&CC=CN&NR=116549456A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MEI JIAJIA</creatorcontrib><creatorcontrib>MINEYAMA</creatorcontrib><creatorcontrib>WEI TAO</creatorcontrib><creatorcontrib>ZHAO JIANYUAN</creatorcontrib><creatorcontrib>REN LILI</creatorcontrib><title>Application of chlorpromazine in preparation of coronavirus inhibitor</title><description>The invention discloses an application of chlorpromazine in preparation of a coronavirus inhibitor. The invention provides application of chlorpromazine or pharmaceutically acceptable salt thereof, which is (a) or (b) or (c) or (d) as follows: (a) application in preparation of a coronavirus inhibitor; (b) application in inhibition of coronavirus; (c) application in product preparation; the product is used for treating diseases caused by coronavirus infection. And (d) application in treating diseases caused by coronavirus infection. Experiments prove that chlorpromazine has good anti-SARS-CoV-2 activity and/or anti-HCoV-OC43, and has an important application prospect in the treatment of SARS-CoV-2 infection and/or HCoV-OC43 infection.
本发明公开了氯丙嗪在制备冠状病毒抑制剂中的应用。本发明提供了氯丙嗪或其在药学上可接受的盐的应用，为如下(a)或(b)或(c)或(d)：(a)在制备冠状病毒抑制剂中的应用；(b)在抑制冠状病毒中的应用；(c)在制备产品中的应用；所述产品的用途为治疗冠状病毒感染引起的疾病；(d)在治疗冠状病毒感染引起的疾病中的应用。本发明通过实验证明氯丙嗪具有良好的抗SARS-CoV-2活性和/或抗HCoV-OC43，具有重要的治疗SARS-CoV-2感染和/或HCoV-OC43感染的应用前景。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB1LCjIyUxOLMnMz1PIT1NIzsjJLyooys9NrMrMS1XIzFMoKEotSCxCKMgvys9LLMssKi0GymZkJmWW5BfxMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQzNTE0sTUzNHY2LUAABcDjQo</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>MEI JIAJIA</creator><creator>MINEYAMA</creator><creator>WEI TAO</creator><creator>ZHAO JIANYUAN</creator><creator>REN LILI</creator><scope>EVB</scope></search><sort><creationdate>20230808</creationdate><title>Application of chlorpromazine in preparation of coronavirus inhibitor</title><author>MEI JIAJIA ; MINEYAMA ; WEI TAO ; ZHAO JIANYUAN ; REN LILI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116549456A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MEI JIAJIA</creatorcontrib><creatorcontrib>MINEYAMA</creatorcontrib><creatorcontrib>WEI TAO</creatorcontrib><creatorcontrib>ZHAO JIANYUAN</creatorcontrib><creatorcontrib>REN LILI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MEI JIAJIA</au><au>MINEYAMA</au><au>WEI TAO</au><au>ZHAO JIANYUAN</au><au>REN LILI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of chlorpromazine in preparation of coronavirus inhibitor</title><date>2023-08-08</date><risdate>2023</risdate><abstract>The invention discloses an application of chlorpromazine in preparation of a coronavirus inhibitor. The invention provides application of chlorpromazine or pharmaceutically acceptable salt thereof, which is (a) or (b) or (c) or (d) as follows: (a) application in preparation of a coronavirus inhibitor; (b) application in inhibition of coronavirus; (c) application in product preparation; the product is used for treating diseases caused by coronavirus infection. And (d) application in treating diseases caused by coronavirus infection. Experiments prove that chlorpromazine has good anti-SARS-CoV-2 activity and/or anti-HCoV-OC43, and has an important application prospect in the treatment of SARS-CoV-2 infection and/or HCoV-OC43 infection.
本发明公开了氯丙嗪在制备冠状病毒抑制剂中的应用。本发明提供了氯丙嗪或其在药学上可接受的盐的应用，为如下(a)或(b)或(c)或(d)：(a)在制备冠状病毒抑制剂中的应用；(b)在抑制冠状病毒中的应用；(c)在制备产品中的应用；所述产品的用途为治疗冠状病毒感染引起的疾病；(d)在治疗冠状病毒感染引起的疾病中的应用。本发明通过实验证明氯丙嗪具有良好的抗SARS-CoV-2活性和/或抗HCoV-OC43，具有重要的治疗SARS-CoV-2感染和/或HCoV-OC43感染的应用前景。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116549456A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Application of chlorpromazine in preparation of coronavirus inhibitor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A28%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MEI%20JIAJIA&rft.date=2023-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116549456A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |